A study to assess the pharmacokinetics of Camizestrant (AZD9833) when Administered Alone and in Combination with Itraconazole

Trial Identifier: D8532C00003
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT05551897
Start Date: October 2022
Primary Completion Date: December 2022
Study Completion Date: December 2022
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations